T-DM1 Boosts Survival in HER2-Positive Breast Cancer ...Middle East

Patients with HER-2 positive early breast cancer with residual invasive disease after neoadjuvant therapy were randomly assigned to receive either T-DM1 or trastuzumab for 14 cycles. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( T-DM1 Boosts Survival in HER2-Positive Breast Cancer )

Also on site :

• Sharon Osbourne says she disinvited greedy band from Ozzy’s Black Sabbath farewell concert: ‘It’s not the time to make a profit’
• 46-year-old Buena Park man posts bail after fireworks blast that killed 8-year-old girl
• Watch Live: A bird's eye view of Chicago's NASCAR road course